PKBOW
Income statement / Annual
Last year (2024), Peak Bio, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Peak Bio, Inc.'s net income was -$1.68 K.
See Peak Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$367.88 K |
$0.00 |
$528.31 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$107.10
|
$108.58
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$170.90
|
| Gross Profit |
$0.00
|
$367.77 K
|
$607.57 K
|
$528.31 K
|
$0.00
|
$0.00
|
$0.00
|
-$170.90
|
| Gross Profit Ratio |
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$1.63 M
|
$0.00
|
$7.12 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$292.34
|
$218.68
|
$8.53 M
|
$2.47 M
|
$332.09
|
$173.88
|
$133.70
|
$98.74
|
| Selling & Marketing Expenses |
$117.80
|
$9.06
|
$0.00
|
$0.00
|
$99.02
|
$16.94
|
$448.23
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.67 K
|
$1.25 K
|
$8.53 M
|
$2.47 M
|
$2.35 K
|
$1.23 K
|
$581.93
|
$98.74
|
| Other Expenses |
$0.00
|
$0.00
|
-$819.06 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.67 K
|
$1.25 K
|
$753.22
|
$9.59 M
|
$2.61 K
|
$1.27 K
|
$581.93
|
$98.74
|
| Cost And Expenses |
$1.67 K
|
$1.36 K
|
$12.46 M
|
$9.59 M
|
$2.35 K
|
$1.23 K
|
$581.93
|
$269.64
|
| Interest Income |
$140.06
|
$202.80
|
$2.11 K
|
$160.00
|
$149.30
|
$1.56
|
$7.30
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$47.96 K
|
$11.47 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$87.50
|
$54.73
|
$786.48 K
|
$176.65 K
|
$39.27
|
$8.37
|
$5.01
|
$0.25
|
| EBITDA |
-$1.67 K |
-$1.36 K |
-$12.33 M |
-$8.02 M |
-$2.35 K |
-$1.23 K |
-$581.93 |
-$269.64 |
| EBITDA Ratio |
0
|
-0
|
0
|
-15.18
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
-0
|
0
|
-17.16
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$2.66
|
$239.67 K
|
-$44.14
|
$855.02 K
|
-$107.97
|
-$37.41
|
$7.37
|
-$45.54
|
| Income Before Tax |
-$1.68 K
|
-$1.26 K
|
-$905.93
|
-$8.21 M
|
-$2.46 K
|
-$1.27 K
|
-$574.56
|
-$315.18
|
| Income Before Tax Ratio |
0
|
-0
|
0
|
-15.54
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$74.00 K
|
$82.07 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$1.68 K
|
-$1.26 K
|
-$905.93
|
-$8.29 M
|
-$2.46 K
|
-$1.27 K
|
-$574.56
|
-$315.18
|
| Net Income Ratio |
0
|
-0
|
0
|
-15.7
|
0
|
0
|
0
|
0
|
| EPS |
-0.0192 |
-4.26241E-5 |
-0.74 |
-0.48 |
-0.0004 |
-0.0003 |
-0.0173 |
-0.0143 |
| EPS Diluted |
-0.0209 |
-4.26241E-5 |
-0.74 |
-0.48 |
-0.0004 |
-0.0003 |
-0.0173 |
-0.0143 |
| Weighted Average Shares Out |
$80.33 K
|
$29.54 M
|
$17.71 M
|
$20.06 M
|
$6.72 M
|
$36.40 K
|
$33.29 K
|
$22.11 K
|
| Weighted Average Shares Out Diluted |
$87.10 K
|
$29.54 M
|
$17.71 M
|
$20.06 M
|
$6.72 M
|
$36.40 K
|
$33.29 K
|
$22.11 K
|
| Link |
|
|
|
|
|
|
|
|
